Notes / Company

Lasa Supergenerics Ltd.

LASA BSE 540702 ISIN INE670X01014 Pharmaceuticals

Fundamentals

Market cap: ₹38.08 cr
ROE: 0.00%
Debt / equity: 0.23
52-week range: 5.67 — 14.08

Research on Tijori Finance

Company snapshot

Lasa Supergenerics Ltd.

Pharmaceuticals

₹37 cr

Latest quarter · Mar 2026

Sales−₹0 cr

Net profit−₹4 cr

Op. margin+1605.3%

EPS−₹0.83

Strength & growth

Debt / equity0.23×

Current ratio0.78×

Sales CAGR−24.8%

The timeline — 1 note on Lasa Supergenerics Ltd.

May 2026

29 May 26 · 7:50 PM IST Brief

Brief · Earnings · Micro cap

Lasa's factory burned down. Its auditors don't trust its books.

Revenue fell 82% to ₹25 cr after an uninsured fire shut the main plant. A ₹38 cr GST demand now equals the company's market cap.

Verify on exchange BSE filings for LASA NSE filings for LASA Tijori Finance company page